Burning Rock Biotech Ltd (BNR) insider trading.
In Q3 2026, insiders at Burning Rock Biotech Ltd reported 7 non-derivative transactions on 1 Forms 3, 4 and 5: 7 open-market purchases worth $6.2M and 0 sales.
- Transactions
- 7
- Purchases (P)
- 7
- Sales (S)
- 0
- Net shares, P minus S
- 731,410
- Insiders
- 1
- Last filed
- 2026-07-02
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Han Yusheng | Director | 7 | 7 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-06-26 | Han Yusheng | P (A) | 24,900 | $8 | 18,404,086 | Form 4 |
| 2026-06-24 | Han Yusheng | P (A) | 250,000 | $8 | 18,379,186 | Form 4 |
| 2026-06-23 | Han Yusheng | P (A) | 5,990 | $7.5 | 18,129,186 | Form 4 |
| 2026-06-22 | Han Yusheng | P (A) | 104,650 | $7.45 | 18,123,196 | Form 4 |
| 2026-06-16 | Han Yusheng | P (A) | 111,110 | $9 | 18,018,546 | Form 4 |
| 2026-06-12 | Han Yusheng | P (A) | 210,000 | $9.25 | 17,907,436 | Form 4 |
| 2026-06-11 | Han Yusheng | P (A) | 24,760 | $8.74 | 17,697,436 | Form 4 |
Transaction codes in this quarter
Get BNR insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1792267&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · BNR company page · Burning Rock Biotech Ltd on SEC.gov
Questions
Are insiders buying or selling Burning Rock Biotech Ltd (BNR)?
In Q3 2026, insiders at Burning Rock Biotech Ltd reported 7 non-derivative transactions on 1 Forms 3, 4 and 5: 7 open-market purchases worth $6.2M and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Burning Rock Biotech Ltd insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/bnr.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.